Introduction
============

Prosthetic joint surgery is a medical-technical success which offers an improved quality of life to many patients. However, in rare cases, the primary joint implants may become infected, with long-lasting prosthetic joint infections (PJIs) as a result. PJI is a complication affecting 1-2% of hip and knee arthroplasties [@B1],[@B2]. These infections account for significant health care expenses due to prolonged hospitalization, long-term antimicrobial treatment, and revision surgeries, as well as increased mortality and morbidity, with patients suffering disability and pain [@B1],[@B2]. *Staphylococcus aureus* and coagulase-negative staphylococci (CoNS), predominantly *S. epidermidis*, are the most common aetiological agents of PJIs [@B1],[@B2]. These staphylococci are part of the human normal flora, colonizing both the skin and mucous membranes, including the nares.The presence of microorganisms in a surgical wound is a prerequisite for the establishment of an infection, and the pathogens are commonly regarded as originating from the patient\'s endogenous flora. Pre-operative strategies in order to reduce the number of bacteria on the skin, and accordingly wound contamination, include preoperative showers with antiseptic agents such as chlorhexidine soap. However, bacteria can almost always be isolated from a surgical wound. Nasal colonization with *S. aureus* is a risk factor for surgical site infections such as PJIs [@B3]. Furthermore, previous studies have shown that nasal decolonization of *S. aureus* with mupirocin has been effective in reducing surgical site infections and thus decreasing the occurrence of deep PJIs [@B4].

Mupirocin, also known as pseudomonic acid A, is an antibiotic agent originally extracted from *Pseudomonas fluorescens*. It acts on bacterial isoleucyl-t-RNA synthetase and therefore inhibits the protein synthesis [@B5]. Due to the degradation of acids in the human body, the agent can only be administrated topically on the skin and mucous membranes, and so it is manufactured as ointment. Emerging resistance due to point mutations in *MupA* and *MupB* genes involved in encoding isoleucyl-tRNAs have been reported [@B5],[@B6].

Decolonization with intranasal mupirocin, in combination with topical chlorhexidine baths, has also been used in neonates at intensive care units with the aim of decreasing infections caused by methicillin-resistant *Staphylococcus aureus* (MRSA) [@B7]. However, the presence of high levels of resistance to mupirocin among CoNS isolated from preterm neonates has been reported [@B8].

The aim of the present study was to investigate susceptibility to mupirocin among *S. epidermidis* isolated from PJIs and nasal isolates from patients intended to undergo prosthetic joint replacements. If *S. epidermidis* present in the nares, and thereby also on the human skin, can be eradicated by the use of topical mupirocin before arthroplastic surgery, this may offer a way to prevent PJIs.

Methods and materials
=====================

A total of 183 isolates of *S. epidermidis* obtained during revision surgery from patients with PJIs of the hip (n=126), knee (n=41), shoulder (n=12), or elbow (n=4) at the University Hospitals of Örebro and Linköping from 1999 to 2015 and from 1993 to 2015, respectively were included. In addition, nasal isolates (n=75) from patients intended to undergo prosthetic joint replacements from 2013 to 2015 were used for comparison. All isolates were identified as *S. epidermidis* by MALDI-TOF MS (Microflex LT and Biotyper 3.1, Bruker Daltonics, Bremen, Germany). The isolates were stored in preservation medium (Trypticase soy broth with 0.3% yeast extract and 29% horse serum) at -70°C pending further analysis. In addition, 75 nasal isolates of *S. epidermidis* were obtained from patients prior to elective arthroplastic surgery.

Antibiotic susceptibility testing by disc diffusion test was performed according to EUCAST guidelines (<http://www.eucast.org>). Multi-drug resistance (MDR) was defined as resistance against ≥ 3 antibiotic classes. The antibiotics tested were fusidic acid 10µg, gentamicin 10µg, erythromycin 15µg, clindamycin 2µg, sulphamethoxazole-trimethoprim 25µg, rifampicin 5µg, norfloxacin 10µg, and cefoxitin 30µg (all discs from Oxoid, Basingstoke, UK). The clinical breakpoints were according to the recommendations of EUCAST. The minimum inhibitory concentration (MIC) for mupirocin was determined by Etest (bioMérieux, Marcy l\'Etoile, France). The breakpoints for nasal decolonization of *S. aureus* according to NordicAST (<http://www.nordicast.org>) is S ≤1 mg/L and R \>256 mg/L, respectively.

Results
=======

All but three isolates of *S. epidermidis* from PJIs were fully susceptible to mupirocin, with MIC values ranging from 0.064 to \>1024 mg/L (Figure [1](#F1){ref-type="fig"}a). MIC~50~ and MIC~90~ were 0.125 and 0.19, respectively. All but one of the nasal *S. epidermidis* isolates were susceptible to mupirocin, with MIC values ranging from \<0.064 to \>1024 mg/L (Figure [1](#F1){ref-type="fig"}b). MIC~50~ and MIC~90~ were again 0.125 and 0.19, respectively.

The results of the antibiotic susceptibility testing of *S. epidermidis* isolated from PJIs and nares, respectively, are shown in Table [1](#T1){ref-type="table"}. The majority of the PJI isolates displayed resistance against various antibiotic agents, and 154/183 (84.2%) were found to be MDR. Resistance to methicillin, investigated by using cefoxitin (\< 24 mm zone diameter), was present in 137/183 (74.9%) of PJI isolates and 5/75 of nasal isolates (6.7%) (p\<0.0001; Fisher\'s exact test). The majority of the 75 isolates obtained from the nares were susceptible to most of the tested antibiotic agents (Table [1](#T1){ref-type="table"}). Two of the nasal isolates displayed the MDR phenotype (p\<0.0001; Fisher\'s exact test).

Discussion
==========

This study investigated the antimicrobial susceptibility of *S. epidermidis* isolated from PJIs and nares, with a special focus on the antimicrobial agent mupirocin. The purpose of the investigation was to find out if *S. epidermidis* isolates present in the nares of patients intended to undergo elective implant surgery were susceptible to mupirocin, and thus if nasal eradication of *S. epidermidis* with mupirocin could be a strategy for preventing PJI.

Since antimicrobial susceptibility testing for mupirocin of the nasal *S. epidermidis* isolates showed that almost all isolates were susceptible, it could be possible, in parallel with eradication strategies for *S. aureus* [@B3],[@B4],[@B7],[@B8], to eradicate a nasal carriership of *S. epidermidis.* Thus, the use of mupirocin ointment as a topical treatment in the nares before surgery could be hypothesized to prevent surgical site infections and PJIs caused by the commensal, yet possibly invasive, *S. epidermidis.*

This finding of high susceptibility to mupirocin among *S. epidermidis* isolated both from the nares and from PJIs is not fully consistent with previous studies from France [@B9], where 6.6% of CoNS isolated from nostrils of patients admitted for orthopaedic surgery were resistant to mupirocin, and from the US [@B10], where 24% of CoNS isolated from PJIs were resistant. In the present study, 1.3% of CoNS isolated from nares of orthopaedic surgery patients and 1.6% from PJIs, respectively, were not fully susceptible to mupirocin. This indicates that it is important to investigate local conditions regarding mupirocin sensitivity before commencing mupirocin prevention strategies for post-operative infections. In Sweden, mupirocin is not routinely used for decolonization pre-operatively. The consumption of mupirocin is very limited and mainly restricted to eradication of MRSA carriership.

There was a significant difference in prevalence of MDR between *S. epidermidis* isolated from the nares and from PJIs; the MDR phenotype was almost absent among isolates from nares, but present in the majority of the PJI isolates. This indicates that strains causing PJIs do not obviously originate from the nares, and thus may not be part of the normal flora of the patients prior to arthroplastic surgery. Furthermore, we have previously shown that the dominating sequence types (ST) among PJI isolates were ST2 and ST215 compared to a wide diversity among commensals by applying MLST [@B11]. The origin of the MDR *S*. *epidermidis* isolates of patients affected by PJIs thus becomes an intriguing question. Is there an alteration of the skin flora following the pre-operative chlorhexidine showers, and subsequent re-colonization by MDR *S*. *epidermidis* from the hospital environment and/or hospital staff? Further studies regarding the origin of MDR *S. epidermidis* causing PJIs are highly warranted and of great importance in order to better understand the pathogenesis of PJI and to prevent PJIs.

In conclusion, the majority of *S. epidermidis* isolates obtained both from nares and PJIs were susceptible to mupirocin. However, MDR was found in most of the PJI isolates but only in a few isolates from the nares, indicating that *S. epidermidis* causing PJIs do not represent colonizers of the nares and hence the normal skin flora. The origin of these MDR *S. epidermidis* thus has to be sought elsewhere.
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###### 

Antibiotic susceptibility testing of S. epidermidis isolates obtained from prosthetic joint infections (PJIs) and from nares of patients intended for elective arthroplastic surgery. Multi-drug resistance (MDR) was defined as resistance against ≥3 antibiotic classes.

  ----------------------------------------------------------------------------
                       PJIs (n=183)Resistant (%)   Nares (n=75)Resistant (%)
  -------------------- --------------------------- ---------------------------
  Cefoxitin            137 (74.9%)                 5 (6.7%)

  Fusidic acid         81 (44.3%)                  8 (10.7%)

  Clindamycin          105 (57.4%)                 2 (2.7%)

  Erythromycin         115 (62.8%)                 14 (18.7%)

  Gentamicin           130 (71.0%)                 2 (2.7%)

  Rifampicin           52 (28.4%)                  0 (0%)

  Sulfamethoxazole/\   134 (73.2%)                 7 (9.3%)
  trimethoprim                                     

  Norfloxacin          148 (80.9%)                 3 (4.0%)

  Mupirocin            3 (1.6%)                    1 (1.3%)

  MDR                  154 (84.2%)                 2 (2.7%)
  ----------------------------------------------------------------------------
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